These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Half-sandwich iridium N-heterocyclic carbene anticancer complexes. Wang C; Liu J; Tian Z; Tian M; Tian L; Zhao W; Liu Z Dalton Trans; 2017 May; 46(21):6870-6883. PubMed ID: 28405646 [TBL] [Abstract][Full Text] [Related]
4. DFT Investigation of the Mechanism of Action of Organoiridium(III) Complexes As Anticancer Agents. Ritacco I; Russo N; Sicilia E Inorg Chem; 2015 Nov; 54(22):10801-10. PubMed ID: 26492153 [TBL] [Abstract][Full Text] [Related]
5. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents. Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276 [TBL] [Abstract][Full Text] [Related]
6. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963 [TBL] [Abstract][Full Text] [Related]
7. Contrasting reactivity and cancer cell cytotoxicity of isoelectronic organometallic iridium(III) complexes. Liu Z; Salassa L; Habtemariam A; Pizarro AM; Clarkson GJ; Sadler PJ Inorg Chem; 2011 Jun; 50(12):5777-83. PubMed ID: 21618978 [TBL] [Abstract][Full Text] [Related]
9. The potent oxidant anticancer activity of organoiridium catalysts. Liu Z; Romero-Canelón I; Qamar B; Hearn JM; Habtemariam A; Barry NP; Pizarro AM; Clarkson GJ; Sadler PJ Angew Chem Int Ed Engl; 2014 Apr; 53(15):3941-6. PubMed ID: 24616129 [TBL] [Abstract][Full Text] [Related]
10. Half-Sandwich Iridium(III), Rhodium(III), and Ruthenium(II) Complexes Chelating Hybrid sp Guo L; Li P; Li J; Gong Y; Li X; Liu Y; Yu K; Liu Z Inorg Chem; 2023 Sep; 62(37):15118-15137. PubMed ID: 37671819 [TBL] [Abstract][Full Text] [Related]
11. Novel iridium(III) iminopyridine complexes: synthetic, catalytic, and in vitro anticancer activity studies. Kong D; Tian M; Guo L; Liu X; Zhang S; Song Y; Meng X; Wu S; Zhang L; Liu Z J Biol Inorg Chem; 2018 Jul; 23(5):819-832. PubMed ID: 29934699 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships for highly potent half-sandwich organoiridium(III) anticancer complexes with C^N-chelated ligands. Yang Y; Guo L; Ge X; Shi S; Gong Y; Xu Z; Zheng X; Liu Z J Inorg Biochem; 2019 Feb; 191():1-7. PubMed ID: 30445339 [TBL] [Abstract][Full Text] [Related]
13. Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis. Hearn JM; Romero-Canelón I; Qamar B; Liu Z; Hands-Portman I; Sadler PJ ACS Chem Biol; 2013; 8(6):1335-43. PubMed ID: 23618382 [TBL] [Abstract][Full Text] [Related]
14. Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity. Li J; Guo L; Tian Z; Tian M; Zhang S; Xu K; Qian Y; Liu Z Dalton Trans; 2017 Nov; 46(44):15520-15534. PubMed ID: 29090698 [TBL] [Abstract][Full Text] [Related]
18. Triphenylamine-Appended Half-Sandwich Iridium(III) Complexes and Their Biological Applications. He X; Tian M; Liu X; Tang Y; Shao CF; Gong P; Liu J; Zhang S; Guo L; Liu Z Chem Asian J; 2018 Jun; 13(11):1500-1509. PubMed ID: 29645357 [TBL] [Abstract][Full Text] [Related]
19. Reduction- and pH-Sensitive Hyaluronan Nanoparticles for Delivery of Iridium(III) Anticancer Drugs. Cai Z; Zhang H; Wei Y; Wei Y; Xie Y; Cong F Biomacromolecules; 2017 Jul; 18(7):2102-2117. PubMed ID: 28605176 [TBL] [Abstract][Full Text] [Related]